Cora Sternberg

From Wikipedia, the free encyclopedia
Cora Sternberg
Born1951 (age 69–70)
Philadelphia
NationalityAmerican
Alma materSapienza University of Rome University of Pennsylvania
AwardsOrder of Merit of the Italian Republic

Cora Sternberg (born 1951) is an American medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital, serving as a member of the Genitourinary (GU) Oncology Program. Dr. Sternberg facilitates the continued growth and development of clinical and translational research programs in GU malignancies, with a particular emphasis on expanding the overall research portfolio. As Clinical Director of the Englander Institute for Precision Medicine (EIPM), Dr. Sternberg will develop strategies to incorporate genomic sequencing and precision medicine throughout the Weill Cornell Medicine and NewYork-Presbyterian healthcare network, including Lower Manhattan, Brooklyn and Queens.

Dr. Sternberg previously served as chief of the medical oncology department at San Camillo-Forlanini Hospital in Rome, Italy, and adjunct professor at Sapienza University of Rome.[1][2] Sternberg is an elected board member of the European Organisation for Research and Treatment of Cancer (EORTC).[3]

She has been awarded the title ‘Grande Ufficiale al Merito della Repubblica Italiana’ and has received the Premio Minerva for Scientific Achievement, XVIII Edition for Achievements in Science.[4] Sternberg has received the Premio ROSA “Risultati Ottenuti Senza Aiuti", award for special achievement from the Canova Club in 2011.[citation needed]

Biography[]

Born in Philadelphia, Sternberg earned her undergraduate degree at the College of Women at the University of Pennsylvania and her medical degree at the University of Pennsylvania in Philadelphia. She also obtained a second medical degree at the University of Rome La Sapienza.[5]

Upon transferring to Italy, Sternberg became a Consultant Physician at the Regina Elena Cancer Institute for Cancer Research, 1st Division of Medical Oncology in Rome, Italy. She then went on to become a Consultant Oncologist at the C.T.O. Hospital in Rome, Italy and subsequently Chief of the Department of Medical Oncology at the San Raffaele Scientific Institute in Rome, Italy and Consultant in Medical Oncology at the Regional General Hospital F. Miulli in Acquaviva delle Fonti, in Bari, Italy. From Fall 2002 - 2018 she was the Chief of the Department of Medical Oncology at the San Camillo-Forlanini Hospital in Rome, Italy.[6]

Honors and awards[]

Works[]

  • Co-editor: Vito Pansadoro and Cora N. Sternberg. Il Carcinoma Infiltrante della Vescica. Accademia Nazionale di Medicina: Forum per la Formazione Biomedica. Sezione Urologia. Rome, 1994.
  • Co-editor: Seth Lerner, Mark Schoenberg and Cora N. Sternberg. Comprehensive Textbook on Bladder Cancer. Taylor and Frances.Abington Oxon OX14 4 RN, England, 2006
  • Co-editor: Hein van Poppel, J.J.M.C.H. Delarosette and Cora N. Sternberg. Textbook on Renal Cell Cancer: Diagnosis and Therapy. Springer Verlag London, 2008
  • Co-editor: Seth Lerner, Mark Schoenberg and Cora N. Sternberg. Textbook on Treatment Management of Bladder Cancer. Informa UK Ltd, 2008

See also[]

References[]

  1. ^ Sternberg CN, Hawkins RE, Wagstaff J, Salman P, Mardiak J, Barrios CH, Zarba JJ, Gladkov OA, Lee E, Szczylik C, McCann L, Rubin SD, Chen M, Davis ID (April 2013). "A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update". European Journal of Cancer. 49 (6): 1287–1296. doi:10.1016/j.ejca.2012.12.010. PMID 23321547.
  2. ^ Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, Weiselberg L, Rosado K, Smart T, Lin S, Penenberg D, Fair WR, Whitmore WF (15 December 1989). "Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse". Cancer. 64 (12): 2448–2458. doi:10.1002/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7. PMID 2819654.
  3. ^ "Dr. Cora Sternberg presented the long term results of EORTC trial 30994 at ASCO 2014 in Chicago". EORTC. 4 June 2014. Retrieved 20 January 2018.
  4. ^ "Oncologia. A Cora Sternberg il premio Esmo Award 2013 - Quotidiano Sanità". Quotidianosanita.it. Retrieved 20 January 2018.
  5. ^ McKillop, Christine (1 April 2007). "Interview with Dr Cora N. Sternberg: Prostate Cancer Chemotherapy". European Urology. pp. 1136–1138. doi:10.1016/j.eururo.2007.01.037. Retrieved 20 January 2018.
  6. ^ "Two High-Risk Prostate Cancer Treatments Have Similar Benefits, Add-On Study Finds". Prostate Cancer News Today. 12 September 2017. Retrieved 20 January 2018.
  7. ^ "A oncologa Cora Sternberg del Forlanini assegnato Esmo Award 2013". Pharmastar.it. Retrieved 20 January 2018.
Retrieved from ""